Mattia Galli On Genomadix Cube Test: A Rapid Genetic Test to Predict The Response to Clopidogrel
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, reposted from Mater Dei General Hospital on LinkedIn:
”Would you take a life-saving drug knowing that in one case out of three this does not work? Probably not.
In the heart of Rome, one of the first centers in Italy to finally offer the possibility of predicting the response to the most widely used anti-caking drug, clopidogrel, with a simple and rapid genetic test.
The result of the test is integrated with the most up-to-date international recommendations on the subject, to which I had the honor of contributing, to offer a personalized assessment and improve the prognosis of patients in each specific clinical context.
After years of scientific research, it is time to turn science into real benefits for a more targeted and personalized care of cardiovascular patients.”
Mater Dei General Hospital shared on LinkedIn:
”What is the Genomadix Cube test?
It is a simple and non-invasive genetic test that helps to understand how our body responds to some fundamental drugs in cardiology, such as antiplatelet drugs that inhibit P2Y12 (clopidogrel, prasugrel or ticagrelor)
Let’s find out more with Dr. Mattia Galli
Info and reservations
Tel. 06 83 803”
Read the full article in JACC.
Article: International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update
Authors: Dominick J. Angiolillo, Mattia Galli, Dimitrios Alexopoulos, Daniel Aradi, Deepak L. Bhatt, Laurent Bonello, Davide Capodanno, Larisa H. Cavallari, Jean-Philippe Collet, Thomas Cuisset, Jose Luis Ferreiro, Francesco Franchi, Tobias Geisler, C. Michael Gibson, Diana A. Gorog, Paul A. Gurbel, Young-Hoon Jeong, Rossella Marcucci, Jolanta M. Siller-Matula, Roxana Mehran, Franz-Josef Neumann, Naveen L. Pereira, Konstantinos D. Rizas, Fabiana Rollini, Derek Y.F. So, Gregg W. Stone, Robert F. Storey, Udaya S. Tantry, Jurrien Ten Berg, Dietmar Trenk, Marco Valgimigli, Ron Waksman, Dirk Sibbing
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2025, 15:47Shannon Farmer: Congratulations to Susan Goobie and Colleagues on Publication of Their Important Study
-
Nov 15, 2025, 15:46Fotios Barkas: Explore the Latest Articles From the Journal of Atherosclerosis Prevention and Treatment!
-
Nov 15, 2025, 15:45Ludovic Helfgott: Researchers Have Analysed Novo Nordisk Product Data in Obesity and Cardiovascular Disease
-
Nov 15, 2025, 15:42Haroun Gajraj Thanks Enric Roche for Demonstrating the Piston Effect
-
Nov 15, 2025, 15:41Thrombectomy Rates Rise 700% Nationwide
-
Nov 15, 2025, 15:41Emmanuel J. Favaloro: Transitioning Patients from DOACs to Heparin
-
Nov 15, 2025, 15:40Bruno Lima: I Owe a Lot of My Career to Dr. Brad Maron
-
Nov 15, 2025, 15:39Ramesh Balasubramanian: Future of Hematology is Encouraging. Striving Towards More Cure for the Dreaded Cancer
-
Nov 15, 2025, 15:37Atrial Fibrillation Increases the Risk of Stroke by Up to Fivefold Due to Clot Formation in the Atria